Kiki Chang

Publication Details

• Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder.

  Chang K, Nayar D, Howe M, Rana M. J Child Adolesc Psychopharmacol. 2009; 19 (5): 547-51

  Atomoxetine has been proposed to be effective for treating co-morbid attention-deficit/hyperactivity disorder (ADHD) in children with bipolar disorder (BPD) without destabilizing mood. We conducted an 8-week, open label study to study the efficacy and tolerability of adjunct atomoxetine in euthymic children and adolescents with BPD and ADHD.

  PubMedID: 19877979